Skip to main content

Table 1 Baseline characteristics of BC brain metastases (BCBM) patients included from SEER data cohort

From: Novel models by machine learning to predict prognosis of breast cancer brain metastases

Characteristic

 

Cases

%

Age at diagnosis

 < 40

141

7.29

40–49

251

12.98

50–59

529

27.37

60–69

576

29.80

70–79

307

15.88

80 + 

129

6.67

Months from diagnosis to therapy

0 month

877

45.37

 ≥ 1 month

739

38.23

Unknown

317

16.40

Subtype

HR + /HER2−

717

37.09

HR + /HER2 + 

308

15.93

HR−/HER2 + 

239

12.36

HR−/HER2−

333

17.23

Unknown

336

17.38

Race

White

1447

74.86

Black

307

15.88

Other

179

9.26

Histological type

IDC

1259

65.13

ILC

97

5.02

Mixed

70

3.62

Other

507

26.23

Marital status

Married

790

40.87

Singled

495

25.61

Widow/divorced/other

648

33.52

T Stage

T1

196

10.14

T2

412

21.31

T3

248

12.83

T4

640

33.11

Unknown

437

22.61

N Stage

N0

378

19.56

N1

802

41.49

N2

171

8.85

N3

280

14.49

Unknown

302

15.62

Grade

Well differentiated

67

3.47

Moderate differentiated

448

23.18

Poorly differentiated

756

39.11

Unknown

662

34.25

Median household income(inflation adjusted)

< 40,000$

104

5.38

40,000–49,999$

219

11.33

50,000–59,999$

292

15.11

60,000–69,999$

642

33.21

70,000$ + 

676

34.97

Chemotherapy

No/unknown

878

45.42

Yes

1055

54.58

Radiotherapy

No/unknown

757

39.16

Yes

1176

60.84

Surgery

No/unknown

1699

87.89

Yes

234

12.11

Bone metastases

No/unknown

680

35.18

Yes

1253

64.82

Liver metastases

No/unknown

1289

66.68

Yes

644

33.32

Lung metastases

No/unknown

1092

56.49

Yes

841

43.51

Distant lymph nodes metastases

No/unknown

1649

85.31

Yes

284

14.69

Distant other metastases

No/unknown

1720

88.98

Yes

213

11.02